The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sajankumar Bajaj
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sajankumar Bajaj, Chairman & Managing Director and Promoter of Bajaj Healthcare Ltd, has disclosed the conversion of 4,55,074 convertible warrants into equity shares on 18th March 2026. As a result, his voting rights holding increased from 35.26% to 36.62% on a diluted basis (1,18,70,700 to 1,23,25,774 shares). The total equity share capital of the company rose from 3,15,83,252 to 3,36,62,661 shares, indicating that other warrant holders also converted their warrants during this allotment. This is not an open market purchase but the conversion of pre-existing instruments held by the promoter.
This is a positive signal as the promoter is increasing his equity stake in the company, reflecting confidence in the business. However, since the conversion also increased total shares outstanding, the promoter's overall percentage holding only modestly improved. No immediate stock price impact is expected, though it reinforces promoter commitment to the company.